GOLDMAN Sachs and JP Morgan have completed the sale of stock in Pharmacia & Upjohn (P&U), the three year old pharmaceuticals group formed through the merger of the US and Swedish groups. The deal was executed on an extremely fast time-table, illustrating the benefits of using this type of marketing during turbulent market conditions. Although the offering was launched in last week's booming stockmarkets, the situation changed abruptly this week with the exposure of Brazil's economic, political and currency problems. But the outstanding stock in P&U was relatively insulated from the turmoil, allowing the lead managers to price the placement close to the $55-1/16 closing price in New York last night (Thursday).
January 15, 1999